The Motley Fool

Key Data Points

Primary metrics and data points about Rexahn Pharmaceuticals.
Current Price: $0.61
Prev Close: $0.60
Open: $0.61
Bid: $0.61
Ask: $0.61
Day's Range: $0.60 - $0.61
52wk Range: $0.60 - $0.96
Volume: 182,421
Avg Vol 701,228
Market Cap: $110M
P/E (ttm): -15.12
EPS (ttm): ($0.04)
Div & Yield: $0.00 (0.0%)

News and Headlines

Latest news about Rexahn Pharmaceuticals from

Business Summary

Industry, sector and description for Rexahn Pharmaceuticals.

Rexahn Pharmaceuticals Inc. is a clinical stage biopharmaceutical company developing and seeking to deliver novel cures for cancer and disorders of the central nervous system (CNS) to patients worldwide.

  • Exchange: NYSEMKT
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

RNN vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Rexahn Pharmaceuticals.
CAPS Rating 3 out of 5
97 Outperform
15 Underperform
CAPS All Stars
14 Outperform
4 Underperform

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Chang H. Ahn, CEO

0% Approve

Based on 0 Ratings

Powered by

More Details about Rexahn Pharmaceuticals

Primary metrics and data points about Rexahn Pharmaceuticals.